Chronic Treatment with Metformin Has No Disrupting Effect on the Hepatic Circadian Clock in Mice

• Published in: Medicina (Kaunas, Lithuania) Vol. 58; no. 2; p. 293
• Main Authors: Hasan, Nazmul, Sugimoto, Koki, Yamada, Koki, Morishige, Jun-Ichi, Ushijima, Kentaro, Fujimura, Akio, Nagata, Naoto, Ando, Hitoshi
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 15.02.2022; MDPI
• Subjects: Animals; Antidiabetics; Body fat; Circadian Clocks - genetics; Circadian rhythm; Circadian Rhythm - physiology; clock genes; Diabetes; Drinking water; Experiments; Food; Gene expression; Glucose; Kinases; Liver; Metabolic disorders; Metformin; Mice; Mice, Inbred C57BL; Obesity; type 2 diabetes; Variance analysis; United States > US; Japan; metformin; clock genes; type 2 diabetes; liver; circadian rhythm
• ISSN: 1648-9144; 1010-660X; 1648-9144
• DOI: 10.3390/medicina58020293

: The antidiabetic agent metformin is known to activate AMP-activated protein kinase (AMPK) in various tissues. Because AMPK can modulate intracellular circadian clocks through regulating the stability of clock components, a single dose of metformin has been reported to affect circadian clocks in the peripheral tissues. In this study, therefore, we investigated whether chronic treatment with metformin causes the impairment of circadian clocks, especially if given at an inappropriate time. : Non-diabetic C57BL/6J mice were allowed access to food only during 4 h at the beginning of the dark period, and repeatedly i.p. injected with a nearly maximum non-toxic dose of metformin, once daily either at 4 h after the beginning of the dark period or at the beginning of the light period. Diabetic ob/ob mice were given free access to food and treated with metformin in drinking water. Results: Under the controlled feeding regimen, 8-day treatment with metformin did not alter the mRNA expression rhythms of clock genes in both liver and adipose tissue of C57BL/6J mice, regardless of dosing time. In addition, chronic treatment with metformin for 2 weeks affected hepatic AMPK activation rhythm but did not disrupt the circadian clocks in the liver and adipose tissues of the ob/ob mice. : These results mitigate concerns that treatment with metformin impairs peripheral circadian clocks, although confirmation is needed in humans.